Australia: Dr Richard Kwiatek, rheumatologist, Adelaide

Hutan

Moderator
Staff member
Dr Richard Kwiatek sees people with fibromyalgia and ME/CFS. I'm trying to understand if he is a safe people for people with those diseases to consult.

He is Medical Advisor to Fibromyalgia Australia and to the Bridges and Pathways Institute
Bridges and Pathways (B&P) works to improve research and services for Australians disadvantaged by ME/CFS (Chronic Fatigue Syndrome), Fibromyalgia and associated conditions.

ME/CFS/FM are debilitating, multi-factorial, long-term physical conditions that affect over 500,000 Australians who struggle to access best-practice medical care and appropriate allied health and community services.


Our programs are based on a grassroots community empowerment model, offering hope and helping people adjust to living with a complex chronic condition that requires medical and lifestyle interventions.


We work as part of the South Australian primary care network. Our services include a national call line (phone, email, and Facebook), accredited education management programs, support with care plans and annual cycle of care management programs for patients. We work in partnerships with providers to improve management and practice resources including research.



There is a 2017 podcast interview with the Australian Prescriber - link. There is a transcript there.

At its essence it's just what we call functional somatic symptoms where pain is very predominant as a symptom.

There's a lot of talk about associations with psychological distress and psychiatric disorders.

We think that fibromyalgia is an adrenal stress response to the body, that is somatic symptoms occur in response to some form of stress, physical or psychological, but when those stresses go away there's a tendency for those maladaptive changes tp persist s that makes clinical assessment complex.

But, there is the suggestion that there are real physical differences
Mainstream medicine’s having difficulty with this because, at least at a superficial level, on examination there are no objective findings and so it has been a contested diagnosis. But now we're finding in a lot of research there, at least in cross-sectional studies, there's a lot of objective changes in correlations being detected both at the anatomical level, at a pathophysiological level and at a chemical level and cellular level.

There's a growing appreciation that functional somatic syndromes in general have associated sensory system sensitisation. In fibromyalgia they have sensitisation of their pain system and so we have a complex situation which requires high-level clinical skills to fully evaluate, and in general practice this is clearly very demanding.

At a practical level we need to work out whether they’ve got peripheral pain generators, any form of arthritis, either in the spine or on the periphery, whether they are psychologically distressed, whether they're on inappropriate medications which may be promoting weight gain because weight causes metabolic inflammation.

There is the suggestion that non-pharmacological approaches (physical, psychological and lifestyle-associated changes are 'only moderately effective'. But the application of medications seems to be with the intent that symptoms are quietened down enough to allow the person to engage effectively with the non-pharmacological treatments that, it is inferred, address the root cause.

The more traditional, non-pharmacological approaches on average are only modestly effective. Their effect sizes are all less than one. There is an argument by some people that we should not rely on pharmacological treatments because it promotes passive illness behaviour and therefore patients should be weaned off medications as quickly as possible and concentrate on the non-pharmacological approaches, physical, psychological and lifestyle-associated changes. The reality is they're actually not that potent in the vast majority of people.

So with regards to medications though, we have evidence at least with milnacipran that the effects of these medications can go on for many years, if you withdraw the medication the symptoms come back, so we need to target them to the major symptoms which these people have. Pain is obviously a major one for all of them but many of them have sleep disturbance and they have a psychological distress and we can pick and choose the various medications depending on how they work and try and quieten down the symptoms to make it easier for patients to embark upon the non-pharmacological approaches.
 
Back
Top Bottom